Ori Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Ori Biotech's estimated annual revenue is currently $15.8M per year.
- Ori Biotech's estimated revenue per employee is $155,000
- Ori Biotech's total funding is $139.1M.
Employee Data
- Ori Biotech has 102 Employees.
- Ori Biotech grew their employee count by 24% last year.
Ori Biotech's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Process Development | Reveal Email/Phone |
2 | Head Cell Processing | Reveal Email/Phone |
3 | VP Commercial Operations | Reveal Email/Phone |
4 | Head Architecture | Reveal Email/Phone |
5 | Director, Business Development | Reveal Email/Phone |
6 | Associate Director, Consumables | Reveal Email/Phone |
7 | Chief Technology Officer | Reveal Email/Phone |
8 | Associate Director, Hardware | Reveal Email/Phone |
9 | Associate Director, Project Management | Reveal Email/Phone |
10 | Global Finance Director | Reveal Email/Phone |
Ori Biotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.5M | 27 | -7% | N/A | N/A |
#2 | $4096.4M | 10837 | 2% | N/A | N/A |
What Is Ori Biotech?
Ori Biotech is a London- and New Jersey-based innovator in CGT manufacturing that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalised, lifesaving treatments. By fully automating and standardising CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing. So complex manufacturing challenges can be put where they belong – in the past.
keywords:N/A
$139.1M
Total Funding
102
Number of Employees
$15.8M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ori Biotech News
Ori Biotech Raises $30m in Series A financing to advance innovation in cell and gene therapy manufacturing 15-10-2020 October 14 2020, London, UK and Woodcliff Lake, NJ – Ori Biotech Ltd (Ori), a leading innovator in cell and gene therapy (CGT) manufacturing, today announced the successful clo ...
Ori Biotech Raises $30m in Series A financing to advance innovation in cell and gene therapy manufacturing 15-10-2020 October 14 2020, London, UK and Woodcliff Lake, NJ – Ori Biotech Ltd (Ori), a leading innovator in cell and gene therapy (CGT) manufacturing, today announced the successful clo ...
Ori Biotech Ltd, a London, UK-and New Jersey-based cell and gene therapy (CGT) manufacturing company, closed a $30m Series A financing round, bringing total funding to date to $41m. The round was led by Northpond Ventures, alongside Octopus Ventures, with participation from existing institution ...
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.8M | 102 | -3% | $39M |
#2 | $24.8M | 102 | 36% | N/A |
#3 | $14.8M | 102 | 62% | $1M |
#4 | $14.8M | 102 | -1% | N/A |
#5 | $15M | 102 | 10% | N/A |